Dr. Benedetto studies various critical health issues, particularly in the realms of hematology, surgery, and transplantation. He has extensively researched treatments for aggressive cancers such as histiocytic sarcoma and acute myeloid leukemia, investigating the effectiveness of different stem cell transplant methods. Additionally, he has explored outcomes after weight-loss surgery for patients with extreme obesity and the management of blood sugar levels in critically ill trauma patients. His work also addresses kidney health, examining how certain surgeries and treatments impact kidney transplant eligibility for patients undergoing dialysis.
Key findings
Haploidentical stem cell transplants were associated with over 2 times better overall survival compared to cord blood transplants in leukemia patients, with a 2.63 times lower risk of non-relapse mortality.
A case report showed that a young histiocytic sarcoma patient achieved complete recovery after receiving a stem cell transplant four years post-treatment.
In weight-loss surgery patients, complication rates were similar across those with a BMI over 60 and those with a lower BMI, with 19% experiencing complications in both groups.
A new insulin protocol resulted in all trauma patients reaching a safe blood sugar level of less than 140 mg/dL within about 5 hours, maintaining an average of 113.7 mg/dL.
Decellularized cadaver vein allografts did not cause allosensitization in any of the 20 patients, allowing them future eligibility for kidney transplants.
Frequently asked questions
Does Dr. Benedetto study histiocytic sarcoma?
Yes, he examines treatments for histiocytic sarcoma, including the effectiveness of stem cell transplants.
What treatments has Dr. Benedetto researched for leukemia?
He has researched haploidentical and cord blood stem cell transplants, finding that haploidentical transplants improve patient outcomes.
Is Dr. Benedetto's work relevant to kidney transplant patients?
Yes, he studies how different treatments, like hemodialysis access methods, can affect kidney transplant eligibility.
Can patients with a very high BMI safely undergo weight-loss surgery?
Yes, his research shows that patients with a BMI over 60 can have similar complication rates as those with lower BMIs.
What is the focus of Dr. Benedetto's research on trauma patients?
He focuses on improving blood sugar management in critically ill trauma patients to reduce mortality and complications.
Publications in plain English
Durable Response in Histiocytic Sarcoma After Allogeneic Stem Cell Transplantation: A Case Report.
2025
Hematology reports
Oliva S, Gill J, Boccellato E, Mortara U, Molinaro L +8 more
Plain English This study examined a young patient with a rare and aggressive cancer called histiocytic sarcoma (HS), which affected their lymph nodes, spleen, and liver, and also led to a serious condition known as hemophagocytic lymphohistiocytosis. After initial chemotherapy, which didn't fully work, the patient received a stem cell transplant from a matched unrelated donor, resulting in complete recovery over four years later. This case is important because it shows that stem cell transplants can effectively treat HS, even when initial treatments are only partially successful.
Who this helps: Patients with histiocytic sarcoma and their doctors.
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine.
2018
Journal of hematology & oncology
Giannotti F, Labopin M, Shouval R, Sanz J, Arcese W +14 more
Plain English This study looked at two types of stem cell transplants for patients with acute myeloid leukemia: haploidentical transplants using family donors and single umbilical cord blood transplants. Researchers found that patients who received haploidentical transplants had significantly better outcomes, including 2.63 times lower risk of non-relapse mortality and over 2 times better overall survival compared to those who received cord blood transplants. These findings are important because they suggest that haploidentical transplants could offer a safer and more effective treatment option for leukemia patients undergoing this kind of therapy.
Who this helps: Patients with acute myeloid leukemia considering stem cell transplantation.
Is BMI greater than 60 kg/m(2) a predictor of higher morbidity after laparoscopic Roux-en-Y gastric bypass?
2010
Surgical endoscopy
Kushnir L, Dunnican WJ, Benedetto B, Wang W, Dolce C +2 more
Plain English This study looked at whether people with a very high body mass index (BMI) of 60 or more had more complications after a type of weight-loss surgery called laparoscopic Roux-en-Y gastric bypass. The researchers followed 169 patients and found that the complication rates were similar for both those with a BMI under 60 and those with a BMI of 60 or higher, with about 19% of patients in each group experiencing complications. This is important because it shows that surgery can be done safely on very obese patients without an increased risk of problems afterward.
Who this helps: This research benefits super-super morbidly obese patients considering weight-loss surgery.
Sixteen-slice computed tomographic angiography is a reliable noninvasive screening test for clinically significant blunt cerebrovascular injuries.
2006
The Journal of trauma
Biffl WL, Egglin T, Benedetto B, Gibbs F, Cioffi WG
Plain English This study looked at a noninvasive way to detect serious injuries to blood vessels in the neck caused by blunt trauma, using a technology called 16-slice computed tomographic angiography (CTA). Out of 331 patients tested, 18 (5.4%) were found to have these injuries, including 11 injuries to the carotid arteries and 9 to the vertebral arteries, with many related to neck fractures. This finding is important because it shows that using CTA can effectively identify most critical injuries without needing more invasive tests, making screening safer and easier for patients.
Who this helps: This helps doctors and patients involved in trauma care.
Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.
2006
Diabetes technology & therapeutics
Braithwaite SS, Edkins R, Macgregor KL, Sredzienski ES, Houston M +4 more
Plain English This study focused on a new insulin infusion protocol for critically ill trauma patients to improve blood sugar control while reducing the risk of dangerously low blood sugar levels. The doctors tested this protocol on 24 patients and found that all patients reached a safe blood sugar level of less than 140 mg/dL within about 5 hours, and most maintained even lower levels averaging 113.7 mg/dL, with very few experiencing low blood sugar (only 2.4% of measurements were below 70 mg/dL). This is important because better blood sugar management can lead to lower mortality and fewer complications for critically ill patients.
Who this helps: This benefits patients in intensive care, particularly those with trauma.
Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation.
2002
American journal of kidney diseases : the official journal of the National Kidney Foundation
Madden R, Lipkowitz G, Benedetto B, Kurbanov A, Miller M +1 more
Plain English The study examined a new method of processing cadaver veins for use in patients needing hemodialysis, comparing it to a traditional method. Researchers found that none of the 20 patients who received the new treatment (SYN allografts) became sensitized to other people's tissues, while all patients who received the old treatment (CRY allografts) did become sensitized. This is important because it means patients using SYN allografts can still be eligible for kidney transplants in the future.
Who this helps: This benefits patients with kidney failure who require dialysis and may need a transplant later.
Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction.
2001
American journal of kidney diseases : the official journal of the National Kidney Foundation
Benedetto B, Madden R, Kurbanov A, Braden G, Freeman J +1 more
Plain English This study looked at a rare condition called adenine phosphoribosyltransferase (APRT) deficiency that can cause kidney transplant problems. A 42-year-old man had a kidney transplant but later experienced a decline in kidney function because of this deficiency, which was confirmed through tests. Treatment with a specific medication and dietary changes improved his condition, highlighting the importance of quick diagnosis and management of APRT deficiency to help prevent serious kidney issues.
Who this helps: This information benefits patients with kidney transplants and their doctors by raising awareness of a rare but treatable condition.
Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization.
2001
Journal of vascular surgery
Benedetto B, Lipkowitz G, Madden R, Kurbanov A, Hull D +2 more
Plain English This study looked at how using cryopreserved cadaveric vein grafts for hemodialysis affects patients' chances of receiving a kidney transplant later. Researchers found that patients with these grafts had very high levels of antibodies that could make it harder to match them with a donor kidney; specifically, the average "panel reactive antibody" (PRA) value was 84.1% three months after the surgery, compared to just 5.5% in patients waiting for a transplant without grafts. This matters because high PRA levels indicate a risk of rejection for future kidney transplants, meaning these grafts could limit treatment options for patients needing a new kidney.
Who this helps: This information helps patients who need dialysis and may later seek a kidney transplant.